80948-49-8

Basic information

• Product Name: (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide
• CAS NO: 80948-49-8
• Molecular Formula: C₂₄H₄₂N₂O₄
• Molecular Weight: 422.6013
• Mol File: 80948-49-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 625.4°C at 760 mmHg
• Flash Point: 332°C
• Density: 1.174g/cm³
• Vapor Pressure: 2.9E-18mmHg at 25°C
• Refractive Index: 1.562
• CAS DataBase Reference: (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide(80948-49-8)
• EPA Substance Registry System: (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide(80948-49-8)

Safety Data

• Hazardous Substances Data: 80948-49-8(Hazardous Substances Data)

Usage

Description

(3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide is a complex chemical compound with a cholane backbone featuring hydroxyl groups at the 3, 7, and 12 positions, and a hydrazide group at the 24 position. This unique molecular structure, with its hydroxyl and hydrazide functional groups, may offer potential pharmaceutical applications, making it a molecule of interest for drug development and research.

Uses

Used in Pharmaceutical Development:
(3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide is used as a pharmaceutical candidate for its potential therapeutic applications. The presence of hydroxyl and hydrazide groups allows for interactions with other molecules and biological systems, which can be harnessed for the development of new drugs.
Used in Drug Interaction Studies:
In the field of medicinal chemistry, (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholane-24-hydrazide is used as a subject for studying its reactivity and properties. Understanding how this compound interacts with other molecules can provide insights into its potential uses in drug development and therapeutic interventions.
Please note that this is a hypothetical compound, and the mentioned characteristics and uses are based on its chemical structure and potential applications. Further research and development would be required to explore and validate its actual uses in various industries.

Upstream product

• 1448-36-8 methyl cholate 
• 866037-65-2 methoxycarbonylmethyl cholate 
• 81-25-4 cholic acid 
• 15073-99-1 ethyl (3α,5β,7α,12α)-3,7,12-trihydroxycholan-24-oate 

Downstream Products

• 60595-51-9 3α.7α.12α-trihydroxy-5β-cholanoic acid-(24)-(N'-sulfanilyl-hydrazide) 
• 475-31-0 glycocholic acid 
• 81-24-3 Taurocholic acid 
• 1228937-59-4 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-furan-2-ylmethylene]cholan-24-ohydrazide 
• 1228937-61-8 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-thiophen-2-ylmethylene]cholan-24-ohydrazide 
• 1228937-57-2 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-5-methoxy-1H-indole-3-ylmethylene]cholan-24-ohydrazide 
• 1228937-39-0 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-4-methylphenylmethylene]cholan-24-ohydrazide 
• 1228937-34-5 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-4-fluorophenylmethylene]cholan-24-ohydrazide 
• 1228937-35-6 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-4-chlorophenylmethylene]cholan-24-ohydrazide 
• 1228937-45-8 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-4-nitrophenylmethylene]cholan-24-ohydrazide 
• 1228937-32-3 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-phenylmethylene]cholan-24-ohydrazide 
• 1228937-41-4 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-4-methoxyphenylmethylene]cholan-24-ohydrazide 
• 1228937-51-6 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-2-hydroxyphenylmethylene]cholan-24-ohydrazide 
• 1228937-47-0 (3α,5β,7α,12α)-3,7,12-trihydroxy-N-[(1E)-3-chlorophenylmethylene]cholan-24-ohydrazide 

Relevant articles and documents

New cholic acid analogs: Synthesis and 17β-hydroxydehydrogenase (17β-HSD) inhibition activity

The 17β-hydroxysteroid dehydrogenase (17β-HSD) enzyme family is involved in the biosynthesis of active steroids and its inhibition constitutes an interesting approach for treating estrogen-, androgen-dependent cancers and osteoporosis. In this study, a new series of cholic acid analogs was designed with the goal of improving the biological activity as 17β-HSD1 and 17β-HSD2 inhibitors. To this end, 23-cholyl amides 4-7, 3-O-p-toluenesulfonyl-23-cholyl amides 10-12, 23-cholyl-carbohydrazide 14, carbothioamide analog 15, and 23-cholyl-acylhydrazone derivatives 18-22 were synthesized from cholic acid (3) via coupling, sulfonation and substitution reactions. Basic treatment of keto group of 5 with p-bromoaniline afforded 8, meanwhile acidic treatment of 3 with thiosemicarbazide furnished the 23-cholyl-thiadiazole derivative 16. The synthesized compounds were evaluated for their inhibition activity against 17β-HSD1 and 17β-HSD2, and were found inactive at 1.0 μm concentration (inhibition 10%). However, the steroids 12, 21 and 22 showed inhibition of 21.1, 23.9 and 21.3%, respectively, against 17β-HSD2 at the same concentration. Therefore, these steroidal analogs can be further structurally modified to optimize their inhibition activity against 17β-HSD2 for the development of potential therapeutics.

Fluorescent anion sensor derived from cholic acid: The use of flexible side chain

The fluorescent photoinduced electron transfer (PET) chemosensors 1-3 were synthesized from cholic acid. 1 and 2 containing amidothiourea groups as anion receptive sites demonstrated much higher affinity toward anions than 3 containing traditional thioure